A Comparative Study on the efficacy of Tryushanadi Vati with and without Pathya in children suffering from Pratishyaya (~Allergic Rhinitis)
DOI:
https://doi.org/10.47552/ijam.v13i3.2649Keywords:
Pratishyaya, Allergic Rhinitis, Nasasrava, Nasanaha, Kshwathu, KlamaAbstract
Background: Pratishyaya is one of the most common disorders in the pediatric age group. The accumulated Vatadi doshas get to reside in the nose and produce various types of discharges from it which is called Pratishyaya. Pratishyaya is discussed under the 31 Nasagataroga by Acharya Sushruta. It is a disease of KaphaVata dominance characterized by Nasasrava (Nasal discharge), Nasanaha (Nasal Congestion), Shirogourava (Heaviness), Anadhvapihita Nasa (Intermittent nasal Obstruction) and is difficult to cure. Aim: To study the effect of Tryushanadi vati in Pratishyaya. Material & Method: 30 children were randomly selected according to a computer-generated randomized chart and assigned to two groups. In which Tryushanadi Vati and Tryushanadi Vati with Pathya were given according to the age group of 7 days. The results are then interpreted and analyzed statistically. Results: There was a significant improvement in Nasasrava, Nasanaha, Kshwathu (sneezing), and Klama (fatigue). It is the treatment principle that is effective in the Sampraptivighatan (breaking the pathogenesis) of Pratishyaya resulting in the alleviation of features. The overall result after treatment by statistical analysis was 46.87 % in the group of T vati and 57.51% in T vati+P. Statistically, both the groups T vati and T vati +P have shown significant results as per subjective and objective criteria but T vati+P has more efficacy owing to the synergistic effect of Pathya.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.